Megan Michalski

Dr. Megan Michalski

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2019 in Journal of Dental Research
Verified
Journal Article
Open access
MMMegan Michalski
Megan Michalski
LZL.E. Zweifler
L.E. Zweifler
BSB.P. Sinder
B.P. Sinder
AKA.J. Koh
A.J. Koh
JYJ. Yamashita
J. Yamashita
LMLaurie K. McCauley
Laurie K. McCauley
Ineffective oral wound healing is detrimental to patients’ oral health–related quality of life. Delineating the cellular mechanisms involved in optimal healing will elicit better approaches to treating patients with compromised healing. Osteal macrophages have recently emerged as important positive regulators of bone turnover. The contributions of macrophages to long bone healing have been studied, but their role in oral osseous wound healing following tooth extraction is less clear. Clodronate-loaded liposomes were used as a tool to deplete macrophages in C57BL/6J mice and assess oral osseous bone fill after extraction. In addition to macrophage ablation, osteoclast ablation occurred. Interestingly, depletion of macrophages and osteoclasts via clodronate treatment had differential effects based on skeletal location. In the nonwounded tibiae, clodronate treatment significantly increased CD68+ cells and decreased F4/80+ cells in the marrow, which correlated with increased trabecular bone volume fraction after 7 and 14 d. Serum formation and resorptive markers P1NP and TRAcP 5b were decreased as were tibial TRAP+ osteoclasts. In healing extraction sockets, clodronate treatment increased extraction socket trabecular bone thickness at 14 d, which correlated with decreased TRAP+ osteoclasts and F4/80+ macrophages. Conversely, nonwounded maxillary interseptal bone was unaffected by clodronate treatment. Furthermore, the increase in extraction socket bone fill with clodronate was less than the large increase in trabecular bone observed in a nonwounded long bone. These data suggest a temporal and spatial specificity in the roles of macrophages and osteoclasts in normal turnover and healing.

22 February 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MMMegan Michalski
Megan Michalski
ASAnna L. Seydel
Anna L. Seydel
ESErica Siismets
Erica Siismets
LZLaura E. Zweifler
Laura E. Zweifler
AKAmy J. Koh
Amy J. Koh
LMLaurie K. McCauley
Laurie K. McCauley
A prolonged increase in proinflammatory cytokines is associated with osteoporotic and autoimmune bone loss and, conversely, anti‐inflammatory pathways are associated with protection against bone loss. Milk fat globule‐epidermal growth factor (MFG‐E)‐8 is a glycoprotein that is proresolving, regulates apoptotic cell clearance, and has been linked to autoimmune disease and skeletal homeostasis. The role of MFG‐E8 in the young vs. adult skeleton was determined in mice deficient in MFG‐E8 (KO). In vivo , trabecular bone was similar in MFG‐E8KO and wild‐type (WT) mice at 6 and 16 wk, whereas 22 wk adult MFG‐E8KO mice displayed significantly reduced trabecular BV/TV. The number of osteoclasts per bone surface was increased in 22‐wk MFG‐E8 KO vs. WT mice, and recombinant murine MFG‐E8 decreased the number and size of osteoclasts in vitro. Adult MFG‐E8KO spleen weight:body weight was increased compared with WT, and flow cytometric analysis showed significantly increased myeloid‐derived suppressor cells (CD11b hi GR‐1 + ) and neutrophils (CD11b hi Ly6G + ) in MFG‐E8KO bone marrow, suggesting an inflammatory phenotype. PTH‐treated MFG‐E8KO mice showed a greater anabolic response (+124% BV/TV) than observed in PTH‐treated WT mice (+64% BV/TV). These data give insight into the role of MFG‐E8 in the adult skeleton and suggest that anabolic PTH may be a valuable therapeutic approach for autoimmune‐associated skeletal disease.—Michalski, M. N., Seydel, A. L., Siismets, E. M., Zweifler, L. E., Koh, A. J., Sinder, B. P., Aguirre, J. I., Atabai, K., Roca, H., McCauley, L. K. Inflammatory bone loss associated with MFG‐E8 deficiency is rescued by teriparatide. FASEB J. 32, 3730–3741 (2018). www.fasebj.org

26 August 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
MMMegan Michalski
Megan Michalski
BWBart Williams
Bart Williams
The ability to create genetically engineered mouse models (GEMMs) has exponentially increased our understanding of many areas of biology. Musculoskeletal biology is no exception. In this review, we will first discuss the historical development of GEMMs and how these developments have influenced musculoskeletal disease research. This review will also update our 2008 review that appeared in BONEKey, a journal that is no longer readily available online. We will first review the historical development of GEMMs in general, followed by a particular emphasis on the ability to perform tissue-specific (conditional) knockouts focusing on musculoskeletal tissues. We will then discuss how the development of CRISPR/Cas-based technologies during the last decade has revolutionized the generation of GEMMs.

28 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMegan Michalski
Megan Michalski
CDCassandra R. Diegel
Cassandra R. Diegel
ZZZhendong A. Zhong
Zhendong A. Zhong
KSKelly Suino-Powell
Kelly Suino-Powell
LBLevi Blazer
Levi Blazer
BWBart Williams
Bart Williams
It is currently accepted that Wnt receptors, Frizzleds (Fzd), have high functional redundancy, making individual receptors challenging to target therapeutically. Specifically, Fzd2 is believed to be functionally redundant with Fzd1 and Fzd7, findings which were based largely on previously published global knockout mouse studies. Conversely, a Fzd2 global knockout mouse model developed by the International Mouse Phenotype Consortium (IMPC) is early embryonic lethal, suggesting Fzd2 is critical for early embryonic development. If global deletion of Fzd2 leads to early lethality, floxed models are necessary to identify tissue-specific phenotypes. We found that a previously published Fzd2 flox model does not fully delete Fzd2 function. To reconcile the contradictory findings in Fzd2 mouse models and allow for tissue-specific studies of Fzd2, we have generated a new flox model using a modified two-cell homologous recombination CRISPR approach. We demonstrated successful simultaneous insertion of two loxP sites fully surrounding the Fzd2 gene and confirmed cre-mediated recombination deletes the sequence between the loxP sites leading to a Fzd2 null allele. Preliminary studies suggest global knockouts are early embryonic lethal and full characterization of the tissue-specific effects of Fzd2 deletion is currently underway. This work suggests Fzd2 uniquely regulates development and emphasizes the importance of thorough validation of newly generated mouse models.

1 February 2023 in Development
Verified
Journal Article
Open access
PDF file
RLRyan P. Liegel
Ryan P. Liegel
MMMegan Michalski
Megan Michalski
SVSanika Vaidya
Sanika Vaidya
EBElizabeth Bittermann
Elizabeth Bittermann
EFErin Finnerty
Erin Finnerty
RSRolf Stottmann
Rolf Stottmann
Frizzled 2 (FZD2) is a transmembrane Wnt receptor. We previously identified a pathogenic human FZD2 variant in individuals with FZD2-associated autosomal dominant Robinow syndrome. The variant encoded a protein with a premature stop and loss of 17 amino acids, including a region of the consensus dishevelled-binding sequence. To model this variant, we used zygote microinjection and i-GONAD-based CRISPR/Cas9-mediated genome editing to generate a mouse allelic series. Embryos mosaic for humanized Fzd2W553* knock-in exhibited cleft palate and shortened limbs, consistent with patient phenotypes. We also generated two germline mouse alleles with small deletions: Fzd2D3 and Fzd2D4. Homozygotes for each allele exhibit a highly penetrant cleft palate phenotype, shortened limbs compared with wild type and perinatal lethality. Fzd2D4 craniofacial tissues indicated decreased canonical Wnt signaling. In utero treatment with IIIC3a (a DKK inhibitor) normalized the limb lengths in Fzd2D4 homozygotes. The in vivo replication represents an approach for further investigating the mechanism of FZD2 phenotypes and demonstrates the utility of CRISPR knock-in mice as a tool for investigating the pathogenicity of human genetic variants. We also present evidence for a potential therapeutic intervention.

11 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
FYFei Yue
Fei Yue
AKAmy T. Ku
Amy T. Ku
PSPayton D. Stevens
Payton D. Stevens
MMMegan Michalski
Megan Michalski
WJWeiyu Jiang
Weiyu Jiang
YLYi Li
Yi Li
ZNRF3 and RNF43 are closely related transmembrane E3 ubiquitin ligases with significant roles in development and cancer. Conventionally, their biological functions have been associated with regulating WNT signaling receptor ubiquitination and degradation. However, our proteogenomic studies have revealed EGFR as the protein most negatively correlated with ZNRF3/RNF43 mRNA levels in multiple human cancers. Through biochemical investigations, we demonstrate that ZNRF3/RNF43 interact with EGFR via their extracellular domains, leading to EGFR ubiquitination and subsequent degradation facilitated by the E3 ligase RING domain. Overexpression of ZNRF3 reduces EGFR levels and suppresses cancer cell growth in vitro and in vivo , whereas knockout of ZNRF3 / RNF43 stimulates cell growth and tumorigenesis through upregulated EGFR signaling. Together, these data highlight ZNRF3 and RNF43 as novel E3 ubiquitin ligases of EGFR and establish the inactivation of ZNRF3/RNF43 as a driver of increased EGFR signaling, ultimately promoting cancer progression. This discovery establishes a connection between two fundamental signaling pathways, EGFR and WNT, at the level of cytoplasmic membrane receptors, uncovering a novel mechanism underlying the frequent co-activation of EGFR and WNT signaling in development and cancer.